The defense community in Maryland is an R&D powerhouse.
Use this database to see the innovative patents that are poised for commercialization.
Aptamer drug for detoxification of <i>Staphylococcus aureus </i>alpha-toxin
NMRC
Aptamers and methods of use thereof are presented for the treatment or diagnosis of Staphylococcus aureus infection. The aptamers binds to and capable of neutralization of Staphylococcus aureus alpha-toxin.